Advanced Medical Solutions Group 관리
관리 기준 확인 4/4
Advanced Medical Solutions Group CEO는 Chris Meredith, Jan2011 에 임명되었습니다 의 임기는 13.83 년입니다. 총 연간 보상은 £ 813.00K, 46.6% 로 구성됩니다. 46.6% 급여 및 53.4% 보너스(회사 주식 및 옵션 포함). 는 £ 3.82M 가치에 해당하는 회사 주식의 0.83% 직접 소유합니다. 3.82M. 경영진과 이사회의 평균 재임 기간은 각각 4.8 년과 3.8 년입니다.
주요 정보
Chris Meredith
최고 경영자
UK£813.0k
총 보상
| CEO 급여 비율 | 46.6% |
| CEO 임기 | 13.8yrs |
| CEO 소유권 | 0.8% |
| 경영진 평균 재임 기간 | 4.8yrs |
| 이사회 평균 재임 기간 | 3.8yrs |
최근 관리 업데이트
Recent updates
Advanced Medical Solutions Group plc's (LON:AMS) Popularity With Investors Is Under Threat From Overpricing
Nov 18
A Look At The Fair Value Of Advanced Medical Solutions Group plc (LON:AMS)
Sep 07Should You Be Adding Advanced Medical Solutions Group (LON:AMS) To Your Watchlist Today?
Nov 03Advanced Medical Solutions Group plc (LON:AMS) Shares Could Be 38% Below Their Intrinsic Value Estimate
Sep 05Advanced Medical Solutions Group (LON:AMS) Will Want To Turn Around Its Return Trends
Dec 03Are Investors Undervaluing Advanced Medical Solutions Group plc (LON:AMS) By 23%?
Sep 03Advanced Medical Solutions Group's (LON:AMS) Returns On Capital Not Reflecting Well On The Business
Aug 05An Intrinsic Calculation For Advanced Medical Solutions Group plc (LON:AMS) Suggests It's 33% Undervalued
May 31Advanced Medical Solutions Group (LON:AMS) May Have Issues Allocating Its Capital
Apr 23Advanced Medical Solutions Group (LON:AMS) Might Be Having Difficulty Using Its Capital Effectively
Jan 08A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Nov 24Some Investors May Be Worried About Advanced Medical Solutions Group's (LON:AMS) Returns On Capital
May 22A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Apr 10Results: Advanced Medical Solutions Group plc Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 20Should Advanced Medical Solutions Group (LON:AMS) Be Disappointed With Their 30% Profit?
Feb 28The Returns At Advanced Medical Solutions Group (LON:AMS) Provide Us With Signs Of What's To Come
Feb 07
Advanced Medical Solutions Group plc's (LON:AMS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 18How Much Is Advanced Medical Solutions Group plc (LON:AMS) Paying Its CEO?
Dec 28Calculating The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Dec 10The Advanced Medical Solutions Group (LON:AMS) Share Price Is Up 38% And Shareholders Are Holding On
Nov 20CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | UK£11m |
| Mar 31 2024 | n/a | n/a | UK£14m |
| Dec 31 2023 | UK£813k | UK£379k | UK£16m |
| Sep 30 2023 | n/a | n/a | UK£18m |
| Jun 30 2023 | n/a | n/a | UK£20m |
| Mar 31 2023 | n/a | n/a | UK£20m |
| Dec 31 2022 | UK£832k | UK£339k | UK£20m |
| Sep 30 2022 | n/a | n/a | UK£19m |
| Jun 30 2022 | n/a | n/a | UK£18m |
| Mar 31 2022 | n/a | n/a | UK£18m |
| Dec 31 2021 | UK£543k | UK£329k | UK£17m |
| Sep 30 2021 | n/a | n/a | UK£16m |
| Jun 30 2021 | n/a | n/a | UK£14m |
| Mar 31 2021 | n/a | n/a | UK£11m |
| Dec 31 2020 | UK£537k | UK£305k | UK£9m |
| Sep 30 2020 | n/a | n/a | UK£11m |
| Jun 30 2020 | n/a | n/a | UK£14m |
| Mar 31 2020 | n/a | n/a | UK£16m |
| Dec 31 2019 | UK£770k | UK£300k | UK£19m |
| Sep 30 2019 | n/a | n/a | UK£20m |
| Jun 30 2019 | n/a | n/a | UK£21m |
| Mar 31 2019 | n/a | n/a | UK£22m |
| Jan 01 2019 | n/a | n/a | UK£22m |
| Sep 30 2018 | n/a | n/a | UK£22m |
| Jun 30 2018 | n/a | n/a | UK£22m |
| Mar 31 2018 | n/a | n/a | UK£21m |
| Dec 31 2017 | UK£1m | UK£270k | UK£20m |
보상 대 시장: Chris 의 총 보상 ($USD 1.02M )은 UK 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 983.02K ).
보상과 수익: Chris 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Chris Meredith (58 yo)
13.8yrs
테뉴어
UK£813,000
보상
Mr. Andrew Christopher Meredith, also known as Chris, B.Sc. (Hons.) has been the Chief Executive Officer of Advanced Medical Solutions Group plc since January 2011 and served as Chief Operating Officer sin...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Executive Director | 13.8yrs | UK£813.00k | 0.83% £ 3.8m | |
| CFO & Executive Director | 5.8yrs | UK£415.00k | 0.078% £ 356.5k | |
| Group Operations Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Investor Relations Manager | no data | 데이터 없음 | 데이터 없음 | |
| Head of Legal | no data | 데이터 없음 | 데이터 없음 | |
| Group Human Resources Director | 7.5yrs | 데이터 없음 | 데이터 없음 | |
| Chief Commercial Officer | less than a year | 데이터 없음 | 데이터 없음 | |
| Company Secretary | 3.8yrs | 데이터 없음 | 데이터 없음 |
4.8yrs
평균 재임 기간
경험이 풍부한 관리: AMS 의 관리팀은 경험 ( 4.8 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Executive Director | 18.6yrs | UK£813.00k | 0.83% £ 3.8m | |
| CFO & Executive Director | 5.8yrs | UK£415.00k | 0.078% £ 356.5k | |
| Senior Independent Non-Executive Director | 3.8yrs | UK£57.00k | 데이터 없음 | |
| Independent Non-Executive Director | 3.3yrs | UK£54.00k | 데이터 없음 | |
| Independent Non-Executive Chairman | 2.3yrs | UK£46.00k | 0.025% £ 115.1k |
3.8yrs
평균 재임 기간
58yo
평균 연령
경험이 풍부한 이사회: AMS 의 이사회는 경험(평균 재직 기간 3.8 년)으로 간주됩니다.